FDA Approval: Maintenance Lurbinectedin for SCLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of maintenance lurbinectedin plus atezolizumab for extensive stage small cell lung cancer, based on th...
7 Okt 202537min
LCC in Arabic: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC ha...
3 Okt 202524min
Lung Cancer Considered in Dutch: Targeting EGFR NSCLC
As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Lizza Hendriks moderates a discussion in Dutch with Dr. Marthe Paats and Dr. Gerrina Ruiter on the treatmen...
3 Okt 202544min
Lung Cancer Considered: Targeting EGFR NSCLC
Lung Cancer Considered: Targeting EGFR NSCLC by IASLC
3 Okt 202544min
Lung Cancer Considered in Japanese---2025 WCLC Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC ha...
2 Okt 202534min
LCC in Korean: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC ha...
30 Sep 202520min
IASLC Lung Cancer Considered: FDA Approval: Subcutaneous Immunotherapy
This episode of Lung Cancer Considered reviews new and upcoming approvals for subcutaneous immune checkpoint inhibitors. Join host Dr. Narjust Florez and guests, Dr. Cheryl Ho and Dr. Maria Velez Vele...
26 Sep 202545min
LCC in Mandarin: WCLC 2025 Highlights with Experts from Taiwan
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC ha...
18 Sep 202549min
